- Home
- PSTV vs ALUR Comparison
PSTV vs ALUR Comparison
Compare PSTV & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- ALUR
- Stock Information
- Founded
- PSTV 1996
- ALUR 2009
- Country
- PSTV United States
- ALUR United States
- Employees
- PSTV N/A
- ALUR N/A
- Industry
- PSTV Medical/Dental Instruments
- ALUR
- Sector
- PSTV Health Care
- ALUR
- Exchange
- PSTV Nasdaq
- ALUR Nasdaq
- Market Cap
- PSTV 17.0M
- ALUR 18.0M
- IPO Year
- PSTV N/A
- ALUR N/A
- Fundamental
- Price
- PSTV $0.37
- ALUR $3.15
- Analyst Decision
- PSTV Strong Buy
- ALUR Strong Buy
- Analyst Count
- PSTV 3
- ALUR 3
- Target Price
- PSTV $10.83
- ALUR $22.83
- AVG Volume (30 Days)
- PSTV 65.2M
- ALUR 205.1K
- Earning Date
- PSTV 08-13-2025
- ALUR 08-12-2025
- Dividend Yield
- PSTV N/A
- ALUR N/A
- EPS Growth
- PSTV N/A
- ALUR N/A
- EPS
- PSTV N/A
- ALUR N/A
- Revenue
- PSTV $5,206,000.00
- ALUR $28,304,000.00
- Revenue This Year
- PSTV $14.10
- ALUR N/A
- Revenue Next Year
- PSTV $7.96
- ALUR $49.37
- P/E Ratio
- PSTV N/A
- ALUR N/A
- Revenue Growth
- PSTV N/A
- ALUR N/A
- 52 Week Low
- PSTV $0.16
- ALUR $2.15
- 52 Week High
- PSTV $2.31
- ALUR $23.50
- Technical
- Relative Strength Index (RSI)
- PSTV 52.77
- ALUR 64.41
- Support Level
- PSTV $0.27
- ALUR $2.77
- Resistance Level
- PSTV $0.38
- ALUR $3.14
- Average True Range (ATR)
- PSTV 0.03
- ALUR 0.19
- MACD
- PSTV 0.01
- ALUR 0.06
- Stochastic Oscillator
- PSTV 81.82
- ALUR 96.15
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.